| 0 (0%) | 04-23 21:34 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 24.89  |
1-year : | 29.07 |
| Resists | First : | 21.3 |
Second : | 24.89 |
| Pivot price | 20.6 |
|||
| Supports | First : | 20.12 |
Second : | 19.38 |
| MAs | MA(5) : | 20.6 |
MA(20) : | 20.49 |
| MA(100) : | 18.18 |
MA(250) : | 15.6 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.2  |
| %K %D | K(14,3) : | 67.1 |
D(3) : | 50.1 |
| RSI | RSI(14): 60.7 |
|||
| 52-week | High : | 21.3 | Low : | 12.39 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ GNK ] has closed below upper band by 0.9%. Bollinger Bands are 50.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 21.31 - 21.39 | 21.39 - 21.45 |
| Low: | 20.62 - 20.71 | 20.71 - 20.8 |
| Close: | 20.97 - 21.1 | 21.1 - 21.22 |
Tue, 02 Apr 2024
Should You Worry About GenMark Diagnostics, Inc.'s (NASDAQ:GNMK) CEO Salary Level? - Yahoo Movies Canada
Mon, 15 Mar 2021
Roche signs definitive merger agreement with GenMark Diagnostics, Inc., to access novel technology to test for broad ... - GlobeNewswire
Thu, 25 Feb 2021
GenMark Diagnostics Reports Fourth Quarter and Full Year 2020 Results - GlobeNewswire
Thu, 11 Feb 2021
Diagnostics Firm GenMark Said to Explore Sale Amid Interest - Bloomberg
Thu, 09 Jul 2020
GenMark Diagnostics (GNMK) Stock Is a Winner, But How Much Higher Can It Go? - Yahoo Finance
Wed, 10 Jun 2020
TransEnterix (TRXC) Catches Eye: Stock Jumps 6.3% - Yahoo Movies UK
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 43 (M) |
| Shares Float | 40 (M) |
| Held by Insiders | 6.9 (%) |
| Held by Institutions | 55.8 (%) |
| Shares Short | 897 (K) |
| Shares Short P.Month | 1,170 (K) |
| EPS | -0.31 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 21.46 |
| Profit Margin | -3.4 % |
| Operating Margin | 17.8 % |
| Return on Assets (ttm) | 1.9 % |
| Return on Equity (ttm) | -1.4 % |
| Qtrly Rev. Growth | -9 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 8.97 |
| EBITDA (p.s.) | 2.08 |
| Qtrly Earnings Growth | -82.9 % |
| Operating Cash Flow | 92 (M) |
| Levered Free Cash Flow | -52 (M) |
| PE Ratio | -70.41 |
| PEG Ratio | 0.1 |
| Price to Book value | 0.98 |
| Price to Sales | 2.35 |
| Price to Cash Flow | 9.83 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|